A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo˗Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Induction Therapy With 2 Doses of TD-1473 in Subjects With Moderately-to-Severely Active Crohn's Disease
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2019
At a glance
- Drugs TD 1473 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms DIONE
- Sponsors Theravance Biopharma
- 20 Nov 2018 According to a Theravance Biopharma media release, the first patient has been dosed in this study.
- 06 Nov 2018 According to a Theravance Biopharma media release, patient screening is underway in this trial.
- 10 Sep 2018 Status changed from not yet recruiting to recruiting.